The platform places the patient near a broad-area scanning source and far from a small-area detector, an inverse geometry that reduces detected scatter for image quality with lower radiation and geometrically accurate depth information.
The scanning-beam chain of source, detector, and real-time multi-slice reconstruction is covered by issued United States patents. FDA 510(k) marketing clearance and clinical validation at the University of Wisconsin-Madison are documented in company milestone reporting.
NovaRay is a single-platform imaging manufacturer whose current competitors include ARTIS icono from Siemens Healthineers, Azurion from Philips, and Allia IGS Pulse from GE HealthCare, each of which maintains a current first-party product page.
The company's historic official domain is unreachable and its public news flow dates to 2008 and 2009, with no current product site. Buyer discovery therefore runs through archived pages and third-party coverage rather than a live first-party product surface.
NovaRay Medical develops cardiac catheterization X-ray imaging systems in Newark, California, operating headquarters and manufacturing from the same Newark site opened in June 2008.
Its imaging platform uses inverse-geometry scanning-beam digital X-ray with a broad-area scanning source and a small-area detector. The source, detector, and real-time reconstruction chain is covered by issued United States patents, received FDA 510(k) marketing clearance, and was clinically validated at the University of Wisconsin-Madison.